OTC allergy asthma medication is a topic that causes considerable confusion, as the two conditions are closely linked yet require very different treatments. Allergic asthma affects millions of people in the UK, with common triggers such as pollen, house dust mites, and pet dander driving both nasal and lower airway symptoms. Whilst several over-the-counter allergy medicines — including antihistamines and intranasal corticosteroid sprays — are available from UK pharmacies, it is essential to understand what these products can and cannot do. This guide explains the OTC options available, how to use them safely, and when to seek professional medical advice.
Summary: OTC allergy asthma medication refers to pharmacy-available treatments such as antihistamines and intranasal corticosteroids that manage allergic rhinitis symptoms, but asthma itself requires a formal diagnosis and prescription treatment from a healthcare professional.
- Second-generation antihistamines (cetirizine, loratadine, fexofenadine) and intranasal corticosteroid sprays are the main OTC allergy treatments available in UK pharmacies.
- Salbutamol reliever inhalers are prescription-only medicines (POM) in the UK and cannot be purchased over the counter.
- Intranasal corticosteroids are NICE first-line treatment for persistent or moderate-to-severe allergic rhinitis and require daily use for full effect.
- Using a salbutamol inhaler more than twice a week for symptom relief indicates potentially inadequate asthma control and warrants a GP review.
- Allergen immunotherapy is available on the NHS for selected patients with confirmed allergic rhinitis and is a specialist-led treatment.
- Suspected side effects from any medicine, OTC or prescribed, should be reported via the MHRA Yellow Card Scheme.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding the Link Between Allergies and Asthma
Allergic asthma occurs when airborne allergens trigger IgE-mediated airway inflammation, causing wheezing, chest tightness, and breathlessness; treating allergic rhinitis effectively can also improve asthma control.
Allergies and asthma are closely connected conditions that frequently occur together — a relationship clinicians refer to as 'allergic asthma' or atopic asthma. When the immune system overreacts to airborne allergens such as pollen, house dust mites, pet dander, or mould spores, it triggers an inflammatory response in the airways. This inflammation causes the characteristic symptoms of asthma: wheezing, chest tightness, shortness of breath, and persistent coughing.
In the UK, asthma affects approximately 5.4 million people (Asthma + Lung UK), and allergic triggers account for a significant proportion of cases. The underlying mechanism often involves immunoglobulin E (IgE)-mediated hypersensitivity, where exposure to an allergen prompts mast cells and eosinophils to release histamine and other inflammatory mediators, causing bronchoconstriction, increased mucus production, and airway swelling. It is worth noting, however, that not all asthma is IgE-mediated; non-allergic and mixed phenotypes also exist, and a clinician can help identify which applies to you.
Allergic rhinitis (hay fever) and asthma often coexist — a concept sometimes described as the 'united airway'. The upper and lower airways share a continuous mucosal lining, and inflammation in the nose and sinuses can worsen lower airway disease. Evidence shows that effectively treating allergic rhinitis can improve asthma control. Recognising your personal triggers — whether seasonal pollen or year-round allergens such as house dust mites — is therefore an important first step towards better management of both conditions.
| OTC Treatment | Examples (UK) | Indicated For | How It Works | Key Limitations | Safety Notes |
|---|---|---|---|---|---|
| Second-generation antihistamines | Cetirizine, loratadine, fexofenadine | Allergic rhinitis, urticaria, hay fever | Blocks H1 histamine receptors; reduces sneezing, itching, runny nose | Limited effect on nasal congestion; does not treat asthma | Avoid sedating antihistamines (e.g. chlorphenamine) when driving |
| First-generation antihistamines | Chlorphenamine | Allergic rhinitis, urticaria | Blocks H1 receptors; more sedating than second-generation options | Causes significant sedation; not preferred for routine use | Do not drive or operate machinery; avoid alcohol |
| Intranasal corticosteroid sprays | Beclometasone dipropionate, fluticasone propionate nasal sprays | Persistent or moderate-to-severe allergic rhinitis | Reduces nasal mucosal inflammation; NICE first-line for persistent rhinitis | No immediate relief; requires 1–2 weeks of daily use for full benefit | Direct spray away from nasal septum; stop if persistent nosebleeds occur |
| Sodium cromoglicate eye drops | Opticrom, various generics | Allergic conjunctivitis | Mast cell stabiliser; prevents histamine release in the eye | Does not relieve nasal or lower airway symptoms | Generally well tolerated; consult pharmacist if wearing contact lenses |
| Salbutamol inhaler (reliever) | Ventolin, Salamol | Acute asthma symptom relief | Short-acting beta-2 agonist; causes rapid bronchodilation | Prescription-only medicine (POM) in the UK — not available OTC | Use >twice weekly for relief indicates poor asthma control; seek GP review |
| Preventer inhaler (ICS) | Beclometasone, budesonide inhalers | Long-term asthma control | Inhaled corticosteroid; reduces chronic airway inflammation (NICE NG80) | Prescription-only; does not replace reliever inhaler for acute symptoms | Never stop without GP advice; use spacer with pMDI to improve delivery |
| Allergen immunotherapy | Sublingual tablets (e.g. grass pollen; NICE-appraised) | Confirmed allergic rhinitis; specialist-selected patients | Desensitises immune response to specific allergens over time | NHS specialist-led only; not an OTC or self-initiated treatment | Requires specialist assessment; may reduce risk of asthma progression |
Over-the-Counter Medications Available in the UK
OTC allergy medicines — including antihistamines and intranasal corticosteroids — treat allergic rhinitis symptoms only; salbutamol inhalers are prescription-only and asthma requires clinician-led diagnosis and management.
Several over-the-counter (OTC) products are available in UK pharmacies to help manage the symptoms of allergic rhinitis and allergic conjunctivitis. It is important to understand that these OTC medicines address allergy symptoms — they do not treat or manage asthma itself. Asthma requires a formal clinical diagnosis and prescription treatment under the supervision of a healthcare professional.
Antihistamines are among the most widely used OTC allergy treatments. Second-generation antihistamines such as cetirizine, loratadine, and fexofenadine are preferred because they cause less sedation than older options such as chlorphenamine. They work by blocking H1 histamine receptors, reducing sneezing, itching, and runny nose, though they have limited effect on nasal congestion. Some strengths and indications of fexofenadine are classified as Pharmacy (P) medicines; a pharmacist can advise on the most appropriate option for your symptoms.
Intranasal corticosteroid sprays, such as beclometasone dipropionate and fluticasone propionate nasal sprays, are available without prescription and are considered first-line treatment for persistent or moderate-to-severe allergic rhinitis by NICE (Clinical Knowledge Summary: Allergic rhinitis). They reduce nasal inflammation effectively and, by improving upper airway control, may indirectly support asthma management. They require regular daily use and do not provide immediate relief.
Sodium cromoglicate eye drops are available OTC for allergic conjunctivitis, a common companion to hay fever.
Salbutamol inhalers are prescription-only medicines (POM) in the UK and cannot be purchased over the counter. If you think you may have asthma, or if you have been prescribed a salbutamol inhaler in the past and need a further supply, please speak to your GP or a pharmacist who can advise on next steps. Self-treating suspected asthma with OTC products alone is not appropriate and may delay necessary diagnosis and treatment.
How to Use OTC Allergy Treatments Safely
Antihistamines should be taken consistently during allergy season, whilst intranasal corticosteroids require daily use for one to two weeks before full benefit is seen; always consult a pharmacist if pregnant, breastfeeding, or on other medicines.
Still have questions? Message our pharmacists for free →
Using OTC medications correctly is vital to ensure both effectiveness and safety. Always read the patient information leaflet supplied with any medicine and follow the recommended dosage instructions. If you are pregnant, breastfeeding, or taking other medications, always consult a pharmacist or GP before starting any new OTC treatment.
For antihistamines:
-
Take at the same time each day during allergy season for consistent symptom control.
-
Avoid sedating antihistamines (e.g., chlorphenamine) if you need to drive or operate machinery.
-
Do not exceed the stated dose; higher doses do not improve efficacy and increase the risk of side effects.
For intranasal corticosteroid sprays:
-
These require regular, daily use to be effective — they do not provide immediate relief.
-
Allow one to two weeks of consistent use before assessing their full benefit.
-
Tilt your head slightly forward and direct the spray away from the nasal septum to reduce the risk of nosebleeds.
-
If you experience persistent nosebleeds or other side effects, stop use and speak to a pharmacist or GP.
If you have been prescribed a salbutamol inhaler by your GP:
-
Use the correct inhaler technique — poor technique is one of the most common reasons for inadequate asthma control. Your pharmacist or practice nurse can demonstrate the correct method.
-
A spacer device significantly improves drug delivery to the lungs when used with a pressurised metered-dose inhaler (pMDI) and is particularly helpful for those who find coordination difficult. Spacers are not compatible with dry-powder inhalers (DPIs).
-
Keep a record of how often you use your reliever inhaler. Using it more than twice a week for symptom relief (not including pre-exercise use) is one of the Royal College of Physicians (RCP) Three Questions indicators that your asthma may not be adequately controlled — seek a review with your GP or practice nurse.
-
A prescribed reliever inhaler should never replace a prescribed preventer inhaler (typically an inhaled corticosteroid).
You should report any suspected side effects from medicines — whether prescribed or purchased OTC — via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk). This helps the MHRA monitor the safety of medicines used in the UK.
Experiencing these side effects? Our pharmacists can help you navigate them →
When OTC Options Are Not Enough
Call 999 immediately for severe asthma attacks with cyanosis or peak flow below 33% of predicted; see your GP if using a reliever inhaler more than twice weekly or if OTC treatments fail to control allergy symptoms.
Whilst OTC allergy medicines can provide meaningful relief for mild, intermittent rhinitis symptoms, they are not appropriate for everyone and have clear limitations. Recognising when self-management is insufficient — and when to seek professional help — is a critical aspect of patient safety.
Call 999 or go to your nearest A&E immediately if you or someone else experiences signs of a severe asthma attack, including:
-
Severe breathlessness that prevents speaking in full sentences
-
Rapid worsening of wheeze or chest tightness that does not improve with a reliever inhaler
-
Blue discolouration of the lips or fingertips (cyanosis)
-
A peak flow reading below 50% of your personal best or predicted value (severe); below 33% is life-threatening
Whilst waiting for emergency help, NHS guidance advises: sit upright; take one puff of your reliever inhaler (salbutamol) every 30 to 60 seconds, up to a maximum of 10 puffs; call 999 if there is no improvement after 10 puffs or if you feel worse at any point.
Make a non-urgent appointment with your GP if:
-
You are using your salbutamol inhaler more than twice a week for symptom relief
-
Your sleep is regularly disturbed by asthma symptoms
-
Allergy symptoms are significantly affecting your quality of life despite OTC treatment
-
You have not had an asthma review in the past 12 months
-
You are unsure whether your symptoms are due to allergy, asthma, or another condition
Children with suspected asthma should always be assessed by a healthcare professional — asthma in children requires clinician-led diagnosis and prescription treatment. Adults with newly presenting respiratory symptoms should similarly seek a formal diagnosis rather than relying on OTC products alone.
NHS and NICE Guidance on Managing Allergic Asthma
NICE NG80 recommends a stepwise approach anchored by a preventer inhaled corticosteroid for long-term asthma control, with annual reviews and a written Personal Asthma Action Plan strongly advised.
NICE and NHS England provide clear, evidence-based frameworks for the diagnosis and management of both asthma and allergic rhinitis. Understanding these guidelines helps patients engage more effectively with their healthcare team.
NICE guideline NG80 (Asthma: diagnosis, monitoring and chronic asthma management) recommends a stepwise approach to asthma treatment. The foundation of long-term asthma control is a preventer inhaler containing an inhaled corticosteroid (ICS), such as beclometasone dipropionate or budesonide. These are prescription-only medicines that reduce chronic airway inflammation and significantly lower the risk of asthma attacks. Reliever inhalers address acute symptoms but do not modify the underlying disease. For some patients, a maintenance and reliever therapy (MART) approach — using a single ICS-formoterol inhaler for both daily prevention and symptom relief — may be appropriate; your GP or asthma nurse can advise whether this applies to you, in line with BTS/SIGN and NICE guidance.
For allergic rhinitis, NICE Clinical Knowledge Summary (CKS) guidance recommends intranasal corticosteroids as first-line treatment for persistent or moderate-to-severe symptoms, with oral antihistamines as an adjunct for sneezing and itching. Where symptoms are severe or inadequately controlled, referral to a specialist allergy clinic may be appropriate. Allergen immunotherapy (desensitisation) is available on the NHS for carefully selected patients with confirmed allergic rhinitis; it is a specialist-led treatment with established evidence, particularly in children, and NICE has appraised specific sublingual immunotherapy products (e.g., for grass pollen allergy). Immunotherapy may reduce the risk of asthma developing or worsening in some patients, though eligibility and safety monitoring require specialist assessment.
The NHS also emphasises the importance of annual asthma reviews with a GP or practice nurse. These reviews assess symptom control using validated tools such as the Royal College of Physicians (RCP) Three Questions, check inhaler technique, and adjust treatment as needed. Patients are encouraged to have a written Personal Asthma Action Plan (PAAP), which provides clear guidance on what to do if symptoms worsen — a tool strongly supported by Asthma + Lung UK.
Speaking to a Pharmacist or GP About Your Symptoms
Community pharmacists can advise on OTC allergy products and refer to a GP when needed; GPs can confirm asthma diagnosis via spirometry, peak flow, and FeNO testing as outlined in NICE NG80.
Community pharmacists in the UK are highly trained healthcare professionals and are often the most accessible first point of contact for allergy queries. They can advise on the most appropriate OTC products for your symptoms, check for interactions with existing medications, and help you use nasal sprays correctly. Many pharmacies in England also offer the NHS Pharmacy First service, which allows pharmacists to assess and treat a range of minor conditions without the need for a GP appointment. It is important to note that Pharmacy First does not include the diagnosis or treatment of asthma, nor the supply of prescription-only inhalers; however, pharmacists can provide advice and refer you to your GP when needed.
When speaking to a pharmacist or GP, it is helpful to describe your symptoms clearly, including:
-
When symptoms occur (seasonal, year-round, or triggered by specific exposures)
-
How frequently you use your reliever inhaler, if prescribed
-
Whether symptoms disturb your sleep or limit daily activities
-
Any previous diagnoses of asthma, eczema, or allergic rhinitis (the 'atopic triad')
Your GP can arrange objective tests to confirm an asthma diagnosis, including spirometry, peak flow monitoring, and FeNO (fractional exhaled nitric oxide) testing — a marker of eosinophilic airway inflammation, as outlined in NICE NG80. For allergy testing, GPs may arrange specific IgE blood tests when clinically indicated. Skin prick testing is typically carried out in specialist allergy clinic settings following referral.
Open, honest communication with your healthcare team is the most effective way to achieve good symptom control. Do not hesitate to raise concerns about your current treatment, ask about stepping up therapy, or request a referral if your symptoms remain poorly controlled despite following recommended guidance. If you experience any suspected side effects from a medicine, report these via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. Your pharmacist or GP is there to support you in making informed, safe decisions about your health.
Frequently Asked Questions
Can I buy asthma inhalers over the counter in the UK?
No. Salbutamol reliever inhalers are prescription-only medicines (POM) in the UK and cannot be purchased over the counter. If you suspect you have asthma or need a further supply of your inhaler, speak to your GP or a pharmacist who can advise on next steps.
Which OTC allergy medicines are recommended for allergic rhinitis in the UK?
NICE recommends intranasal corticosteroid sprays, such as beclometasone or fluticasone nasal spray, as first-line treatment for persistent or moderate-to-severe allergic rhinitis. Second-generation antihistamines such as cetirizine or loratadine can be used alongside these for sneezing and itching.
When should I see a GP instead of using OTC allergy treatments?
You should see a GP if your allergy symptoms are significantly affecting your quality of life despite OTC treatment, if you are using a reliever inhaler more than twice a week, if asthma symptoms disturb your sleep, or if you have not had an asthma review in the past 12 months.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
